Overview
No overview information available.
Background
No background information available.
Indication
用于治疗原发性高血压,该复方制剂用于治疗应用厄贝沙坦或氢氯噻嗪单药不能有效控制血压的患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Irbesartan and Hydrochlorothiazide Capsules | 国药准字H20060811 | 化学药品 | 胶囊剂 | 12/15/2020 | |
Irbesartan and Hydrochlorothiazide Capsules | 国药准字H20130002 | 化学药品 | 胶囊剂 | 12/23/2022 | |
Irbesartan and Hydrochlorothiazide Tablets | 国药准字H20203313 | 化学药品 | 片剂 | 7/16/2020 | |
Irbesartan and Hydrochlorothiazide Tablets | 国药准字H20233450 | 化学药品 | 片剂 | 4/11/2023 | |
Irbesartan and Hydrochlorothiazide Tablets | 国药准字H20203678 | 化学药品 | 片剂 | 12/11/2020 | |
Irbesartan and Hydrochlorothiazide Tablets | 国药准字H20213255 | 化学药品 | 片剂 | 4/7/2021 | |
Irbesartan and Hydrochlorothiazide Tablets | 国药准字HJ20140194 | 化学药品 | 片剂 | 1/12/2023 | |
Irbesartan and Hydrochlorothiazide Tablets | 国药准字H20244074 | 化学药品 | 片剂 | 6/18/2024 | |
Irbesartan and Hydrochlorothiazide Tablets | 国药准字H20213739 | 化学药品 | 片剂 | 9/24/2021 | |
Irbesartan and Hydrochlorothiazide Tablets | 国药准字HJ20240030 | 化学药品 | 片剂 | 5/28/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |